Tradestie Institutional Equity Comparison Engine

OTLK vs CSBR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OTLK Overall Edge

OTLK Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Outlook Therapeutics, Inc. Common Stock (OTLK) driven by superior Valuation, Growth & Margin, Options & Structure while CSBR counters with relative strength in Momentum & Technical. Fundamentally, OTLK trades at 2.9x Forward P/E with 4781.8% operating margin (-99.4% YoY revenue) versus CSBR at 47.0x Forward P/E and -1.5% operating margin (+8.8% YoY). In options structure, OTLK sits in BREAKDOWN (55th %ile IV; Dealer Gamma Walls on Pro) against CSBR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner OTLK
OTLK 2.9x vs CSBR 47.0x Fwd P/E
Growth & Margin Winner OTLK
Op Margin 4781.8% vs -1.5% ยท YoY -99.4% vs +8.8%
Momentum & Technical Winner CSBR
1Y -73.0% vs -32.8% ยท 52W Pos 10% vs 5%
Options & Structure Winner OTLK
BREAKDOWN (55th %ile IV) vs UNCLASSIFIED (N/A IV)
OTLK NASDAQ
Outlook Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.40
-4.04% 1D
Market Cap $107.1M
1M Return -18.82%
1Y Return -73.04%
Forward P/E 2.9x
Unified AI Score
48.6 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 71.0 Mom 64.0
CSBR NASDAQ
Champions Oncology, Inc.
Biological Products, (No Disgnostic Substances)
$4.71
+1.18% 1D
Market Cap $64.7M
1M Return -1.77%
1Y Return -32.79%
Forward P/E 47.0x
Unified AI Score
42.9 / 100 HOLD
Tech 46.0 Fund 47.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OTLK -73.04% CSBR -32.79% Spread: +40.09 pp (CSBR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OTLK TTM Op. Margin: 4781.8% CSBR TTM Op. Margin: -1.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OTLK vs CSBR. Trailing 12-month operating profitability (OTLK 4781.8% vs CSBR -1.5%) and valuation multiples (OTLK 2.9x vs CSBR 47.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OTLK (8) vs CSBR (2)
Institutional Metric OTLK CSBR Criterion Row Winner
Market Capitalization Scale $107.1M $64.7M Larger Scale OTLK
Trailing P/E Ratio Valuation 2.9x 22.9x Lower Multiple OTLK
Forward P/E Ratio Valuation 2.9x 47.0x Lower Multiple OTLK
Revenue Growth (YoY) Growth -99.4% +8.8% Higher Growth CSBR
Operating Margin (TTM) Profitability 4781.8% -1.5% Higher Margin OTLK
Net Profit Margin Profitability 0.0% -1.9% Higher Margin OTLK
Return on Equity (ROE) Capital Efficiency -3.6% -28.4% Higher ROE OTLK
52-Week Range Position Momentum 10% ($0โ€“$3) 5% ($5โ€“$8) Stronger Trend OTLK
Beta / 30D Volatility Risk Regime 1.47ฮฒ ยท 79% Vol 0.36ฮฒ ยท 24% Vol Lower Realized Risk CSBR
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 42.9 / 100 (HOLD) Higher Composite OTLK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OTLK vs CSBR Buy Guide
OTLK BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 55th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OTLK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CSBR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CSBR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OTLK nor CSBR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.